Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers

International Journal of Pharmaceutics

Volumn 278, Issue 2, 2004, Pages 329-342

  Li, Jianshu ^a   Xiao, Huining ^a   Li, Jiehua ^b   Zhong, Yinping ^b  

^a UNIVERSITY OF NEW BRUNSWICK   (Canada)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cationic cyclodextrin polymer; Hemolysis; Human erythrocytes; Inclusion complexes; Morphological changes; Physicochemical analysis

Indexed keywords

BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CHOLINE; DRUG CARRIER; EPICHLOROHYDRIN; NAPROXEN;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HEMOLYSIS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL;

BETA-CYCLODEXTRINS; CYCLODEXTRINS; DRUG CARRIERS; ERYTHROCYTES; HEMOLYSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR WEIGHT; NAPROXEN; POLYMERS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 2942520105     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.03.026     Document Type: Article

References (24)

1. Arias M.J., Moyano J.R., Gines J.M. Investigation of the triamterene-β-cyclodextrin system prepared by co-grinding. Int. J. Pharm. 153:1997;181-189
2. Bettinetti G.P., Mura P., Liguori A., Bramanti G. Solubilization and interaction of naproxen with cyclodextrins in aqueous solution and in the solid state. Farmaco. 44:1989;195-213
3. Fenyvesi E. Cyclodextrin polymers in the pharmaceutical industry. J. Incl. Phenom. 6:1988;537-545
4. Fujii T., Sato T., Tamura A., Wakatsuki M., Kanaho Y. Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cell. Biochem. Pharmacol. 28:1979;613-620
5. Harada A., Furue M., Nozakura S. Inclusion of aromatic compounds by a β-cyclodextrin-epichlorohydrin polymer. Polym. J. 13:1981;777-781
6. Hedges A.R. Industrial application of cyclodextrins. Chem. Rev. 98:1998;2035-2044
7. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:1965;117-212
8. Irie T., Uekama K. Pharmaceutical application of cyclodextrin. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86:1997;147-162
9. Macarak E.J., Kumor K., Weisz P.B. Sulfation and hemolytic activity of cyclodextrin. Biochem. Pharmacol. 42:1991;1502-1503
10. Mura P., Bettinetti G., Melani F., Manderioli A. Interaction between naproxen and chemically modified β-cyclodextrins in the liquid and solid state. Eur. J. Pharm. Sci. 3:1995;347-355
11. Mura P., Faucci M.T., Maestrelli S., Furlanetto S., Pinzauti S. Characterization of physiochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers. J. Pharm. Biomed. Anal. 29:2002;1015-1024
12. Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J. Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186:1989;17-22
13. Rajewski R.A., Traiger G., Bresnahan J., Jaberaboansari P., Stella V.J., Thompson D.O. Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. J. Pharm. Sci. 84:1995;927-932
14. Renard E., Deratani A., Volet G., Sebille B. Preparation and characterization of water soluble high molecular weight β-cyclodextrin- epichlorohydrin polymers. Eur. Polym. J. 33:1997;49-57
15. Schneider H.J., Hacket F., Rudiger V., Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 98:1998;1755-1785
16. Shiotani K., Uehata K., Irie T., Uekama K., Thompson D.O., Stella V.J. Differential effects of sulfate and sulfobutyl ether of β-cyclodextrin on erythrocyte membranes in vitro. Pharm. Res. 12:1995;78-84
17. Simkovic I. Quaternization/cross linking of starch with choline chloride/epichlorohydrin. Carbohydr. Polym. 31:1997;47-51
18. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98:1998;1743-1753
19. Szeman J., Ueda H., Szejtli J., Fenyvesi E., Machida Y., Nagai T. Complexation of several drugs with water-soluble cyclodextrin polymer. Chem. Pharm. Bull. 35:1987;282-288
20. Szeman J., Fenyvesi E., Szejtli J. Water soluble cyclodextrin polymers: their interaction with drugs. J. Incl. Phenom. 5:1987;427-431
21. Uekama K., Otagiri M., Irie T., Seo H., Tsuruoka M. Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble beta-cyclodextrin-epichlorohydrin polymer. Int. J. Pharm. 23:1985;35-42
22. Uekama, K., Irie, T. 1987. In: Duchêne, D. (Ed.), Cyclodextrins and Their Industrial Uses. Editions de Santé, Paris, pp. 395-439.
23. Yudiarto A., Kashiwabara S., Tashiro Y., Kokugan T. Seperation of structural isomers using soluble β-cyclodextrin polymer by ultrafiltration. Sep. Purif. Technol. 24:2001;243-253
24. Zhong N., Ohvo-Rekila H., Ramstedt B., Slotte J.P., Bittman R. Selective removal of palmitic acid from langmuir monolayers by complexation with new quaternary ammonium β-cyclodextrin derivatives. Langmuir. 17:2001;5319-5323